Madrigal Pharmaceuticals grants Nasdaq Rule 5635(c)(4) inducement awards
Madrigal Pharmaceuticals said it granted equity awards on Sept. 1, 2026 under Nasdaq Listing Rule 5635(c)(4).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.